Loading clinical trials...

The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants | Clinical Trials | Clareo Health

COMPLETEDNANCT02132663

The Effects on Growth and Tolerance of a Routine Infant Formula Fed to Term Infants

This clinical trial will evaluate an investigational infant formula with an alternate source of DHA to determine if it provides normal growth and if it is well tolerated by term infants as compared to...

Lead sponsor: Mead Johnson Nutrition•22 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment315

Start dateMay 2014

Last updatedMay 1, 2015

Condition

Growth of Term Infants

Locations shown

Birmingham Pediatric Associates

Birmingham, Alabama

Greenvale Pediatrics - Hoover

Birmingham, Alabama

Southeastern Pediatric Association

Dothan, Alabama

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 1, 2015Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions